Ultrasound-guided laser targets Europe

Article

Intra-Sonix of Burlington, MA, has initiated clinical trials in Germany and Belgium for itsTulip II ultrasound-guided minimally invasive surgery device.Tulip,an earlier generation product, is already approved for marketin Europe and Japan. Intra-Sonix

Intra-Sonix of Burlington, MA, has initiated clinical trials in Germany and Belgium for itsTulip II ultrasound-guided minimally invasive surgery device.Tulip,an earlier generation product, is already approved for marketin Europe and Japan. Intra-Sonix operates a European subsidiarybased in Leuven, Belgium.

The Tulip procedure -- transurethral ultrasound-guided laser-inducedprostatectomy -- provides treatment of benign prostatic hyperplasia(BPH). Tulip II offers full 360º ultrasound viewing of theprostate along with other system upgrades. Worldwide, more thanone million men undergo surgical treatment of BPH annually, thecompany said.

Use of ultrasound imaging indicates tissue depth and anatomicalfeatures while treating BPH with laser surgery. This can helpsurgeons determine which obstructive prostate tissue to target-- and which not to target -- thus expanding the number of potentiallytreatable prostates. The laser causes necrosis of tissue, whichis subsequently sloughed off in small particles during urination.

Intra-Sonix has also initiated a new six-site U.S. clinicalstudy of Tulip, following reclassification of laser treatmentsfor BPH by the Food and Drug Administration last year. An investigationaldevice exemption application has been filed with the FDA for TulipII.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.